NCT07525206
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07525206
Title A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer (AndroMETa-CRC)
Acronym AndroMETa-CRC
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors AbbVie
Indications
Therapies
Age Groups: senior | adult
Covered Countries BEL

Facility Status City State Zip Country Details
Algemeen Ziekenhuis klina /ID# 279331 NOT_YET_RECRUITING Brasschaat Antwerpen 2930 Belgium Details
National Cancer Center Hospital East /ID# 279917 RECRUITING Kashiwa-shi Chiba 277-8577 Japan Details
Dong-A University Medical Center /ID# 279610 RECRUITING Busan Busan Gwang Yeogsi 49201 South Korea Details
Gachon University Gil Medical Center /ID# 279592 RECRUITING Incheon Gyeonggido 21565 South Korea Details
Taipei Medical University Hospital /ID# 280607 RECRUITING Taipei Tainan 110 Taiwan Details
Taipei Medical University - Shuang Ho Hospital, Ministry of Health and Welfare /ID# 279708 RECRUITING New Taipei City 235 Taiwan Details
Tri-Service General Hospital - Neihu Branch /ID# 279768 RECRUITING Taipei 114 Taiwan Details
Taipei Municipal Wan Fang Hospital /ID# 280285 RECRUITING Taipei 116 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field